Risk of a Second Primary Cancer after Non-melanoma Skin Cancer in White Men and Women: A Prospective Cohort Study

English version České info

Background:
Previous studies suggest a positive association between history of non-melanoma skin cancer (NMSC) and risk of subsequent cancer at other sites. The purpose of this study is to prospectively examine the risk of primary cancer according to personal history of NMSC.

Methods and Findings:
In two large US cohorts, the Health Professionals Follow-up Study (HPFS) and the Nurses' Health Study (NHS), we prospectively investigated this association in self-identified white men and women. In the HPFS, we followed 46,237 men from June 1986 to June 2008 (833,496 person-years). In the NHS, we followed 107,339 women from June 1984 to June 2008 (2,116,178 person-years). We documented 29,447 incident cancer cases other than NMSC. Cox proportional hazard models were used to calculate relative risks (RRs) and 95% confidence intervals (CIs). A personal history of NMSC was significantly associated with a higher risk of other primary cancers excluding melanoma in men (RR = 1.11; 95% CI 1.05–1.18), and in women (RR = 1.20; 95% CI 1.15–1.25). Age-standardized absolute risk (AR) was 176 in men and 182 in women per 100,000 person-years. For individual cancer sites, after the Bonferroni correction for multiple comparisons (n = 28), in men, a personal history of NMSC was significantly associated with an increased risk of melanoma (RR = 1.99, AR = 116 per 100,000 person-years). In women, a personal history of NMSC was significantly associated with an increased risk of breast (RR = 1.19, AR = 87 per 100,000 person-years), lung (RR = 1.32, AR = 22 per 100,000 person-years), and melanoma (RR = 2.58, AR = 79 per 100,000 person-years).

Conclusion:
This prospective study found a modestly increased risk of subsequent malignancies among individuals with a history of NMSC, specifically breast and lung cancer in women and melanoma in both men and women.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Risk of a Second Primary Cancer after Non-melanoma Skin Cancer in White Men and Women: A Prospective Cohort Study. PLoS Med 10(4): e32767. doi:10.1371/journal.pmed.1001433
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001433

Souhrn

Zdroje

1. RogersHW, WeinstockMA, HarrisAR, HinckleyMR, FeldmanSR, et al. (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146: 283–287.

2. LewisKG, WeinstockMA (2007) Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol 127: 2323–2327.

3. ChenJG, FleischerABJr, SmithED, KanclerC, GoldmanND, et al. (2001) Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 27: 1035–1038.

4. FrischM, HjalgrimH, OlsenJH, MelbyeM (1996) Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 125: 815–821.

5. HemminkiK, DongC (2000) Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 136: 647–651.

6. MilanT, PukkalaE, VerkasaloPK, KaprioJ, JansenCT, et al. (2000) Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer 87: 283–288.

7. FrischM, MelbyeM (1995) New primary cancers after squamous cell skin cancer. Am J Epidemiol 141: 916–922.

8. WassbergC, ThornM, YuenJ, RingborgU, HakulinenT (1999) Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 80: 511–515.

9. TroyanovaP, DanonS, IvanovaT (2002) Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma 49: 81–85.

10. NugentZ, DemersAA, WisemanMC, MihalcioiuC, KliewerEV (2005) Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 14: 2584–2590.

11. ChenJ, RuczinskiI, JorgensenTJ, YenokyanG, YaoY, et al. (2008) Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 100: 1215–1222.

12. GarlandCF, GarlandFC, GorhamED, LipkinM, NewmarkH, et al. (2006) The role of vitamin D in cancer prevention. Am J Public Health 96: 252–261.

13. ColditzGA, MartinP, StampferMJ, WillettWC, SampsonL, et al. (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123: 894–900.

14. HunterDJ, ColditzGA, StampferMJ, RosnerB, WillettWC, et al. (1990) Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol 1: 13–23.

15. QureshiAA, LadenF, ColditzGA, HunterDJ (2008) Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma. Arch Intern Med 168: 501–507.

16. WhelessL, BlackJ, AlbergAJ (2010) Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 19: 1686–1695.

17. TuohimaaP, PukkalaE, SceloG, OlsenJH, BrewsterDH, et al. (2007) Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 43: 1701–1712.

18. GrantWB (2009) Re: Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 101: 210; author reply 210–211.

19. MaY, ZhangP, WangF, YangJ, LiuZ, et al. (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29: 3775–3782.

20. KahnHS, TathamLM, PatelAV, ThunMJ, HeathCWJr (1998) Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 280: 910–912.

21. RoyleJA, BaadePD, JoskeD, GirschikJ, FritschiL (2011) Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer 105: 1076–1081.

22. HemminkiK, JiangY, SteineckG (2003) Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function? Eur J Cancer 39: 223–229.

23. LeighIM, Newton BishopJA, KripkeML (1996) Skin cancer. Introduction. Cancer Surv 26: 1–6.

24. KripkeML (1994) Ultraviolet radiation and immunology: something new under the sun–presidential address. Cancer Res 54: 6102–6105.

25. EnglishDR, ArmstrongBK, KrickerA, FlemingC (1997) Sunlight and cancer. Cancer Causes Control 8: 271–283.

26. FrankelS, GunnellDJ, PetersTJ, MaynardM, Davey SmithG (1998) Childhood energy intake and adult mortality from cancer: the Boyd Orr Cohort Study. Bmj 316: 499–504.

27. SpitzMR, TilleyBC, BatsakisJG, GibeauJM, NewellGR (1984) Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer 54: 1854–1859.

28. AuWW, WilkinsonGS, TyringSK, LegatorMS, el ZeinR, et al. (1996) Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environ Health Perspect 104 Suppl 3: 579–584.

29. StaceySN, SulemP, JonasdottirA, MassonG, GudmundssonJ, et al. (2011) A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet 43: 1098–1103.

30. RastogiRP, Richa, KumarA, TyagiMB, SinhaRP (2010) Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids 2010: 592980.

31. BerwickM, VineisP (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92: 874–897.

32. WeiQ, MatanoskiGM, FarmerER, HedayatiMA, GrossmanL (1993) DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A 90: 1614–1618.

33. GrossmanL, WeiQ (1995) DNA repair and epidemiology of basal cell carcinoma. Clin Chem 41: 1854–1863.

34. LiC, WangLE, WeiQ (2009) DNA repair phenotype and cancer susceptibility–a mini review. Int J Cancer 124: 999–1007.

35. MitchellD, PanikerL, GodarD (2012) Nucleotide excision repair is reduced in oral epithelial tissues compared with skin. Photochem Photobiol 88: 1027–1032.

36. GospodinovA, IvanovR, AnachkovaB, RussevG (2003) Nucleotide excision repair rates in rat tissues. Eur J Biochem 270: 1000–1005.

37. WelcshPL, SchubertEL, KingMC (1998) Inherited breast cancer: an emerging picture. Clin Genet 54: 447–458.

38. ScullyR, LivingstonDM (2000) In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429–432.

39. KitagishiY, KobayashiM, MatsudaS (2012) Defective DNA repair systems and the development of breast and prostate cancer (Review). Int J Oncol

40. FinnOJ (2012) Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol 23 Suppl 8: viii6–9.

41. CramerDW, FinnOJ (2011) Epidemiologic perspective on immune-surveillance in cancer. Curr Opin Immunol 23: 265–271.

42. BeissertS, SchwarzT (1999) Mechanisms involved in ultraviolet light-induced immunosuppression. J Investig Dermatol Symp Proc 4: 61–64.

43. NarayananDL, SaladiRN, FoxJL (2010) Ultraviolet radiation and skin cancer. Int J Dermatol 49: 978–986.

44. WelshMM, KaragasMR, ApplebaumKM, SpencerSK, PerryAE, et al. (2008) A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions. Carcinogenesis 29: 1950–1954.

45. MurphyGM (2009) Ultraviolet radiation and immunosuppression. Br J Dermatol 161 Suppl 3: 90–95.

46. SchwarzT, SchwarzA (2011) Molecular mechanisms of ultraviolet radiation-induced immunosuppression. Eur J Cell Biol 90: 560–564.

47. de GruijlFR (2008) UV-induced immunosuppression in the balance. Photochem Photobiol 84: 2–9.

48. van DamRM, HuangZ, RimmEB, WeinstockMA, SpiegelmanD, et al. (1999) Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study. Am J Epidemiol 150: 459–468.

49. HanJ, ColditzGA, HunterDJ (2006) Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int J Epidemiol 35: 1514–1521.

50. NanH, XuM, KraftP, QureshiAA, ChenC, et al. (2011) Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet 20: 3718–3724.